Dr. Wesley Ekeruo, MD
What this data tells you about Dr. Ekeruo
Dr. Wesley Ekeruo is an urology physician in Houston, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Ekeruo performed 1,173 Medicare services across 1,012 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ekeruo received a total of $23,627 from 54 pharmaceutical and/or device companies across 255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ekeruo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 369 | $60 | $212 |
| Office visit, established patient (30-39 min) | 128 | $87 | $314 |
| New patient office visit (45-59 min) | 85 | $110 | $483 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $136 | $734 |
| Diagnostic exam of bladder and urethra using an endoscope | 77 | $190 | $1,081 |
| Bladder ultrasound after voiding | 42 | $8 | $112 |
| Ultrasound scan of pelvic region through rectum | 41 | $111 | $498 |
| Office visit, established patient, complex (40-54 min) | 33 | $128 | $421 |
| Initial hospital admission, moderate complexity | 32 | $100 | $401 |
| Biopsy of prostate gland | 27 | $187 | $1,186 |
| New patient office visit (30-44 min) | 26 | $73 | $317 |
| Simple surgical subtotal removal of prostate using laparoscope | 25 | $613 | $4,085 |
| Imaging of urinary tract following injection of a contrast agent | 24 | $20 | $663 |
| Injection, garamycin, gentamicin, up to 80 mg | 22 | $2 | $3 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 21 | $331 | $2,074 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 20 | $61 | $296 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 18 | $231 | $3,721 |
| Suture suspension of urethra to control leakage using an endoscope | 18 | $259 | $3,450 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 18 | $829 | $8,159 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 17 | $567 | $4,340 |
| Repair of nerve with graft | 16 | $279 | $3,787 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 13 | $25 | $146 |
| Hospital follow-up visit, high complexity | 12 | $88 | $302 |
| New patient office visit, complex (60-74 min) | 11 | $162 | $600 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for urology physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ekeruo is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 10% of TX peers, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ekeruo experienced with office visit, established patient (20-29 min)?
Does Dr. Ekeruo receive payments from pharmaceutical companies?
How do Dr. Ekeruo's costs compare to other urology physicians in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology